Connect your AI

LiveOne, Inc. LVO Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

CalAmpCAMP

$0-100%

CenterspaceCSR

$43K-93.9%

Rein Therapeutics, Inc. Common StockRNTX

$0—

Empire State Realty TrustESRT

$5.99M+278%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$28.57M—

Blaize Holdings, Inc. Common StockBZAI

$0-100%

Other financials

Income statement

Revenue$18.9M-1.9%

Gross profit$3.5M-41.2%

Operating income-$4.9M+54.2%

Net income-$7.8M+25.7%

EPS (diluted)-$0.01-150%

Balance sheet

Cash & equivalents$5.4M+30.0%

Total debt$3.3M+1,218%

Total equity-$20.5M-15.6%

Total assets$46.9M+15.7%

Cash flow

Operating cash flow-$2.0M—

CapEx$681.0K-26.4%

Free cash flow-$2.7M—

Valuation

Market cap$86.8M-0.9%

Enterprise value$84.72M+12.6%

P/S1.1×+0.3×

Profitability

Gross margin15.9%-9.6pp

Operating margin-20.1%+7.5pp

Net margin-27.2%+53.2pp

FCF margin-17.8%—

Returns & leverage

Return on equity-599.1%—

Debt / equity0.8×—

Current ratio0.5×0.0×

Where this comes from

Reported directly by LiveOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: LiveOne, Inc.’s 10-K, filed June 29, 2023, on SEC EDGAR. View the filing →

Ask your AI about LiveOne, Inc.'s exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LiveOne, Inc.'s exchange offer (note 12)?: LiveOne, Inc. (LVO) reported exchange offer (note 12) of $189K in Q1 2022.